Thrombospondin has a complex role in cancer, acting both as a tumor suppressor and a promoter depending on the context. TSP-1 and TSP-2 are generally considered to have anti-angiogenic properties, meaning they can inhibit the formation of new blood vessels, which is a critical process in tumor growth and metastasis. However, their role can vary based on the type of cancer and the tumor microenvironment.